Editorial: Lipids, lipoproteins and COVID-19
- PMID: 38028441
- PMCID: PMC10646584
- DOI: 10.3389/fcvm.2023.1293249
Editorial: Lipids, lipoproteins and COVID-19
Keywords: COVID-19; SARS-CoV-2; apolipoprotein; cardiovascular; cerebrovascular; lipids; lipoprotein.
Conflict of interest statement
AJ has a pending patent for fusion protein nanodiscs for the treatment of heart failure and eye disease, is a member of the scientific advisory board of Mobius Scientific, and receives research funding from AstraZeneca and Bitterroot Bio, unrelated to the studies in this manuscript. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
